CIK 0001598646
- Non-accelerated filer
- Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 260784194
- Phone
- +1 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-01 | Ahlholm Frederick W SVP, Chief Accounting Officer | Option exercise · Employee Stock Option (Right to Buy) | −14,381 | 43,143 | ||
| 2017-06-01 | Ahlholm Frederick W SVP, Chief Accounting Officer | Option exercise · Employee Stock Option (Right to Buy) | −7,250 | 49,750 | ||
| 2017-06-01 | Vandervelpen Nico Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2017-06-01 | Kupfer David Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2017-06-01 | Laghrissi-Thode Fouzia Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2017-06-01 | Beer Marc D Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2017-06-01 | Levine Mark S. SVP,General Counsel & Sec. | Option exercise | +17,500 | $5.19 | $91K | 17,500 |
| 2017-06-01 | Levine Mark S. SVP,General Counsel & Sec. | Sale | −17,500 | $11.00 | $193K | 0 |
| 2017-06-01 | Levine Mark S. SVP,General Counsel & Sec. | Option exercise · Employee Stock Option (Right to Buy) | −17,500 | 39,774 | ||
| 2017-03-20 | Beer Marc D Director | Purchase | +25,000 | $7.89 | $197K | 50,000 |
| 2017-03-17 | Beer Marc D Director | Purchase | +25,000 | $8.34 | $209K | 25,000 |
| 2017-02-06 | Race Geoff EVP, CFO & CBO | Sale | −1,692 | $11.00 | $19K | 185,198 |
| 2017-02-06 | Luthringer Remy President & CEO | Option exercise | +2,185 | $4.71 | $10K | 2,185 |
| 2017-02-06 | Luthringer Remy President & CEO | Sale | −2,185 | $11.00 | $24K | 0 |
| 2017-02-06 | Luthringer Remy President & CEO | Option exercise · Stock Option (Right to Buy) | −2,185 | 285,719 | ||
| 2017-02-03 | Race Geoff EVP, CFO & CBO | Sale | −19,758 | $11.02 | $218K | 186,890 |
| 2017-02-03 | Luthringer Remy President & CEO | Option exercise | +32,096 | $4.71 | $151K | 32,096 |
| 2017-02-03 | Luthringer Remy President & CEO | Sale | −32,096 | $11.02 | $354K | 0 |
| 2017-02-03 | Luthringer Remy President & CEO | Option exercise · Stock Option (Right to Buy) | −32,096 | 287,904 | ||
| 2017-01-11 | Reilly Joseph H. SVP & Chief Operating Officer | Option exercise | +1,600 | $4.71 | $8K | 9,933 |
Page 13 of 16 · 305 trades